- REPORT SUMMARY
- TABLE OF CONTENTS
-
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms. Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
The report details the trend, potential and market size of Novel Drug Delivery Systems market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Novel Drug Delivery Systemsmarket, defines the market attractiveness level of Novel Drug Delivery Systems market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Novel Drug Delivery Systems industry, describes the types of Novel Drug Delivery Systems market, the applications of major players and the market size, and deeply analyzes the current situation of the global Novel Drug Delivery Systems market and the development prospects and opportunities of Novel Drug Delivery Systems industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Novel Drug Delivery Systems market in Chapter 13.
By Player:
Shire
Teva
Samyang Biopharmaceuticals
Galen
Amgen
Novartis
Sanofi
Aspen
TOLMAR
UCB (Union Chimique Belge)
Breckenridge Pharmaceuticals
Pfizer
Takeda
Johnson & Johnson
Dr Reddy
AbbVie
AstraZeneca
Celgene
Merck
Gilead Sciences
AMAG Pharmaceuticals
Astellas
Roche
TWi Pharmaceuticals
Bausch?Lomb
By Type:
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
By End-User:
Hospitals & Clinic
Cancer Treatment Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Novel Drug Delivery Systems Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Novel Drug Delivery Systems Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Novel Drug Delivery Systems Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Novel Drug Delivery Systems Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Novel Drug Delivery Systems Market Analysis and Outlook to 2022
-
7.1 Global Novel Drug Delivery Systems Consumption (2017-2022)
-
7.2 United States Novel Drug Delivery Systems Consumption (2017-2022)
-
7.3 Europe Novel Drug Delivery Systems Consumption (2017-2022)
-
7.4 China Novel Drug Delivery Systems Consumption (2017-2022)
-
7.5 Japan Novel Drug Delivery Systems Consumption (2017-2022)
-
7.6 India Novel Drug Delivery Systems Consumption (2017-2022)
-
7.7 South Korea Novel Drug Delivery Systems Consumption (2017-2022)
8 Region and Country-wise Novel Drug Delivery Systems Market Analysis and Outlook to 2028
-
8.1 Global Novel Drug Delivery Systems Consumption Forecast (2022-2028)
-
8.2 United States Novel Drug Delivery Systems Consumption Forecast (2022-2028)
-
8.3 Europe Novel Drug Delivery Systems Consumption Forecast (2022-2028)
-
8.4 China Novel Drug Delivery Systems Consumption Forecast (2022-2028)
-
8.5 Japan Novel Drug Delivery Systems Consumption Forecast (2022-2028)
-
8.6 India Novel Drug Delivery Systems Consumption Forecast (2022-2028)
-
8.7 South Korea Novel Drug Delivery Systems Consumption Forecast (2022-2028)
9 Global Novel Drug Delivery Systems Market Outlook by Types and Applications to 2022
-
9.1 Global Novel Drug Delivery Systems Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Liposomes Consumption and Growth Rate (2017-2022)
-
9.1.2 Global PEGylated Proteins & Polypeptides Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Polymer Nanoparticle Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Protein–drug Conjugates Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Novel Drug Delivery Systems Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals & Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Treatment Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Novel Drug Delivery Systems Market Outlook by Types and Applications to 2028
-
10.1 Global Novel Drug Delivery Systems Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Liposomes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global PEGylated Proteins & Polypeptides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Polymer Nanoparticle Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Protein–drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Novel Drug Delivery Systems Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals & Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Novel Drug Delivery Systems Import and Export Analysis (Top 5 Countries)
-
11.1 Global Novel Drug Delivery Systems Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Novel Drug Delivery Systems Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Novel Drug Delivery Systems Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Novel Drug Delivery Systems Market Competitive Analysis
-
14.1 Shire
-
14.1.1 Shire Company Details
-
14.1.2 Shire Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Shire Novel Drug Delivery Systems Product and Service
-
14.2 Teva
-
14.2.1 Teva Company Details
-
14.2.2 Teva Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Novel Drug Delivery Systems Product and Service
-
14.3 Samyang Biopharmaceuticals
-
14.3.1 Samyang Biopharmaceuticals Company Details
-
14.3.2 Samyang Biopharmaceuticals Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product and Service
-
14.4 Galen
-
14.4.1 Galen Company Details
-
14.4.2 Galen Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Galen Novel Drug Delivery Systems Product and Service
-
14.5 Amgen
-
14.5.1 Amgen Company Details
-
14.5.2 Amgen Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Novel Drug Delivery Systems Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Novel Drug Delivery Systems Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Novel Drug Delivery Systems Product and Service
-
14.8 Aspen
-
14.8.1 Aspen Company Details
-
14.8.2 Aspen Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Aspen Novel Drug Delivery Systems Product and Service
-
14.9 TOLMAR
-
14.9.1 TOLMAR Company Details
-
14.9.2 TOLMAR Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 TOLMAR Novel Drug Delivery Systems Product and Service
-
14.10 UCB (Union Chimique Belge)
-
14.10.1 UCB (Union Chimique Belge) Company Details
-
14.10.2 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product and Service
-
14.11 Breckenridge Pharmaceuticals
-
14.11.1 Breckenridge Pharmaceuticals Company Details
-
14.11.2 Breckenridge Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Breckenridge Pharmaceuticals Novel Drug Delivery Systems Product and Service
-
14.12 Pfizer
-
14.12.1 Pfizer Company Details
-
14.12.2 Pfizer Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Pfizer Novel Drug Delivery Systems Product and Service
-
14.13 Takeda
-
14.13.1 Takeda Company Details
-
14.13.2 Takeda Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Takeda Novel Drug Delivery Systems Product and Service
-
14.14 Johnson & Johnson
-
14.14.1 Johnson & Johnson Company Details
-
14.14.2 Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Johnson & Johnson Novel Drug Delivery Systems Product and Service
-
14.15 Dr Reddy
-
14.15.1 Dr Reddy Company Details
-
14.15.2 Dr Reddy Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Dr Reddy Novel Drug Delivery Systems Product and Service
-
14.16 AbbVie
-
14.16.1 AbbVie Company Details
-
14.16.2 AbbVie Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 AbbVie Novel Drug Delivery Systems Product and Service
-
14.17 AstraZeneca
-
14.17.1 AstraZeneca Company Details
-
14.17.2 AstraZeneca Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 AstraZeneca Novel Drug Delivery Systems Product and Service
-
14.18 Celgene
-
14.18.1 Celgene Company Details
-
14.18.2 Celgene Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Celgene Novel Drug Delivery Systems Product and Service
-
14.19 Merck
-
14.19.1 Merck Company Details
-
14.19.2 Merck Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Merck Novel Drug Delivery Systems Product and Service
-
14.20 Gilead Sciences
-
14.20.1 Gilead Sciences Company Details
-
14.20.2 Gilead Sciences Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.20.3 Gilead Sciences Novel Drug Delivery Systems Product and Service
-
14.21 AMAG Pharmaceuticals
-
14.21.1 AMAG Pharmaceuticals Company Details
-
14.21.2 AMAG Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.21.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Product and Service
-
14.22 Astellas
-
14.22.1 Astellas Company Details
-
14.22.2 Astellas Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.22.3 Astellas Novel Drug Delivery Systems Product and Service
-
14.23 Roche
-
14.23.1 Roche Company Details
-
14.23.2 Roche Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.23.3 Roche Novel Drug Delivery Systems Product and Service
-
14.24 TWi Pharmaceuticals
-
14.24.1 TWi Pharmaceuticals Company Details
-
14.24.2 TWi Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.24.3 TWi Pharmaceuticals Novel Drug Delivery Systems Product and Service
-
14.25 Bausch?Lomb
-
14.25.1 Bausch?Lomb Company Details
-
14.25.2 Bausch?Lomb Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
14.25.3 Bausch?Lomb Novel Drug Delivery Systems Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Novel Drug Delivery Systems
-
Figure Novel Drug Delivery Systems Picture
-
Table Global Novel Drug Delivery Systems Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Novel Drug Delivery Systems Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Novel Drug Delivery Systems Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Novel Drug Delivery Systems Consumption by Country (2017-2022)
-
Figure United States Novel Drug Delivery Systems Consumption and Growth Rate (2017-2022)
-
Table Europe Novel Drug Delivery Systems Consumption and Growth Rate (2017-2022)
-
Figure China Novel Drug Delivery Systems Consumption and Growth Rate (2017-2022)
-
Figure Japan Novel Drug Delivery Systems Consumption and Growth Rate (2017-2022)
-
Figure India Novel Drug Delivery Systems Consumption and Growth Rate (2017-2022)
-
Figure South Korea Novel Drug Delivery Systems Consumption and Growth Rate (2017-2022)
-
Figure Global Novel Drug Delivery Systems Consumption Forecast by Country (2022-2028)
-
Figure United States Novel Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Novel Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Novel Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Novel Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Novel Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Novel Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liposomes Consumption and Growth Rate (2017-2022)
-
Figure Global PEGylated Proteins & Polypeptides Consumption and Growth Rate (2017-2022)
-
Figure Global Polymer Nanoparticle Consumption and Growth Rate (2017-2022)
-
Figure Global Protein–drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals & Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Treatment Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PEGylated Proteins & Polypeptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Polymer Nanoparticle Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Protein–drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals & Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Novel Drug Delivery Systems Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Novel Drug Delivery Systems Export by Region (Top 5 Countries) (2017-2028)
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Novel Drug Delivery Systems Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Novel Drug Delivery Systems Product and Service
-
Table Samyang Biopharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Samyang Biopharmaceuticals Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Samyang Biopharmaceuticals Novel Drug Delivery Systems Product and Service
-
Table Galen (Foundation Year, Company Profile and etc.)
-
Table Galen Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galen Novel Drug Delivery Systems Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Novel Drug Delivery Systems Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Novel Drug Delivery Systems Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Novel Drug Delivery Systems Product and Service
-
Table Aspen (Foundation Year, Company Profile and etc.)
-
Table Aspen Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspen Novel Drug Delivery Systems Product and Service
-
Table TOLMAR (Foundation Year, Company Profile and etc.)
-
Table TOLMAR Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table TOLMAR Novel Drug Delivery Systems Product and Service
-
Table UCB (Union Chimique Belge) (Foundation Year, Company Profile and etc.)
-
Table UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB (Union Chimique Belge) Novel Drug Delivery Systems Product and Service
-
Table Breckenridge Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Breckenridge Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Breckenridge Pharmaceuticals Novel Drug Delivery Systems Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Novel Drug Delivery Systems Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Novel Drug Delivery Systems Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Novel Drug Delivery Systems Product and Service
-
Table Dr Reddy (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy Novel Drug Delivery Systems Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Novel Drug Delivery Systems Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Novel Drug Delivery Systems Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Novel Drug Delivery Systems Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Novel Drug Delivery Systems Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Novel Drug Delivery Systems Product and Service
-
Table AMAG Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table AMAG Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table AMAG Pharmaceuticals Novel Drug Delivery Systems Product and Service
-
Table Astellas (Foundation Year, Company Profile and etc.)
-
Table Astellas Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Novel Drug Delivery Systems Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Novel Drug Delivery Systems Product and Service
-
Table TWi Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table TWi Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table TWi Pharmaceuticals Novel Drug Delivery Systems Product and Service
-
Table Bausch?Lomb (Foundation Year, Company Profile and etc.)
-
Table Bausch?Lomb Novel Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bausch?Lomb Novel Drug Delivery Systems Product and Service
-